IL-8 (CXCL8) Antibody AHC0881 from Thermo Fisher Scientific

Product Specs
ItemIL-8 (CXCL8) Antibody
CompanyThermo Fisher Scientific
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberAHC0881
Quantity100 µg
ApplicationsELISA, Immunohistochemistry, Neutralization, Western Blot
Conjugate/TagUnconjugated
FormatPBS with no preservative; pH 7.2
ReactivityHuman
TargetIL-8 (CXCL8)
IsotypeIgG
HostRabbit
ImmunogenHighly purified (>98% pure) recombinant human endothelial IL-8 (77 amino acid residues)
NCBI Full Gene NameC-X-C motif chemokine ligand 8
NCBI Gene AliasesGCP-1, GCP1, IL8, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8
ClonalityPolyclonal
Storage Temperature-20°C
Antibody TypePrimary
Storage-20°C

Add to Compare List

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Combined application of geranylgeranylacetone and amelogenin promotes angiogenesis and wound healing in human periodontal ligament cellsJournal of cellular biochemistryJuly 1, 2021Yamato H, Sanui T, Yotsumoto K, Nakao Y, Watanabe Y, Hayashi C, Aihara R, Iwashita M, Tanaka U, Taketomi T, et al.

(2) Prognostic and Pathophysiologic Significance of IL-8 (CXCL8) in Biliary AtresiaJournal of Clinical MedicineJune 18, 2021Nimish Godbole et al.Agilent Technologies, Glostrup, Denmark). Commercially available antibody for IL-8 (rabbit polyclonal, AHC0881, ThermoFisher Scientific, Waltham, MA, USA) was used at a dilution of 1:3000 along with the Novolink

(3) Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal CancerClinical and experimental gastroenterologyJanuary 1, 2020Yoshida T, Miura T, Matsumiya T, Yoshida H, Morohashi H, Sakamoto Y, Kurose A, Imaizumi T, Hakamada K.R&D Systems, Minneapolis, MN) at 1:25 dilution and for 20 min with rabbit polyclonal antibodies against IL-8 (AHC0881, Thermo Fisher Scientific, Waltham, MA) at 1:100 dilution. BOND Polymer Refine Table 2 Patient Characteristics Item Value Item Sex:

(4) Prognostic Significance of Lymphocyte Infiltration and a Stromal Immunostaining of a Bladder Cancer Associated Diagnostic Panel in Urothelial CarcinomaDiagnostics (Basel, Switzerland)December 28, 2019Furuya H, Chan OTM, Hokutan K, Tsukikawa Y, Chee K, Kozai L, Chan KS, Dai Y, Wong RS, Rosser CJ.anti-APOE (D12) (#M068-3, mouse monoclonal, dilution 1:200) from MBL Co. (Nagoya, Japan), anti-IL8 (#AHC0881, rabbit polyclonal, dilution 1:200) from Life Technologies, Inc. (Grand Island, NY, USA), anti-CD3 (#ab16669,

(5) Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signatureDiagnostic pathologyNovember 12, 2014Zhang G, Gomes-Giacoia E, Dai Y, Lawton A, Miyake M, Furuya H, Goodison S, Rosser CJ.CO); anti-APOE [3D12] (#M068-3, mouse monoclonal, dilution 1:200) from MBL Co. (Japan); and anti-IL8 (#AHC0881, rabbit polyclonal, dilution 1:200) from Life Technologies, Inc. (Grand Island, NY). Next, slides were

(6) The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinomaBMC cancerMarch 4, 2014Stofas A, Levidou G, Piperi C, Adamopoulos C, Dalagiorgou G, Bamias A, Karadimou A, Lainakis GA, Papadoukakis S, Stravodimos K, et al.

(7) Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significanceBioMed research internationalJanuary 1, 2014Levidou G, Sachanas S, Pangalis GA, Kalpadakis C, Yiakoumis X, Moschogiannis M, Sepsa A, Lakiotaki E, Milionis V, Kyrtsonis MC, et al.

(8) Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversaThe British journal of dermatologyMay 1, 2012Emelianov VU, Bechara FG, Gläser R, Langan EA, Taungjaruwinai WM, Schröder JM, Meyer KC, Paus R.

(9) Interleukin-8, a promising predictor for prognosis of pancreatic cancerWorld journal of gastroenterologyMarch 14, 2012Chen Y, Shi M, Yu GZ, Qin XR, Jin G, Chen P, Zhu MH.

(10) Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasisThe Journal of biological chemistryNovember 12, 2010Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, et al.

(11) Cytokines and growth factors expressed by human cutaneous melanomaCancersMay 7, 2010Elias EG, Hasskamp JH, Sharma BK.

(12) Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer modelThe American journal of pathologyJuly 1, 2008Sasaki T, Nakamura T, Rebhun RB, Cheng H, Hale KS, Tsan RZ, Fidler IJ, Langley RR.

(13) Clinical and biological significance of vascular endothelial growth factor in endometrial cancerClinical cancer research : an official journal of the American Association for Cancer ResearchDecember 15, 2007Kamat AA, Merritt WM, Coffey D, Lin YG, Patel PR, Broaddus R, Nugent E, Han LY, Landen CN Jr, Spannuth WA, et al.

(14) Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic diseaseJournal of translational medicineJuly 6, 2006Wang X, Deavers M, Patenia R, Bassett RL Jr, Mueller P, Ma Q, Wang E, Freedman RS.

(15) Induction of CXC chemokines in A549 airway epithelial cells by trypsin and staphylococcal proteases - a possible route for neutrophilic inflammation in chronic rhinosinusitisClinical and experimental immunologyJune 1, 2006Sachse F, von Eiff C, Stoll W, Becker K, Rudack C.

(16) Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenesThe Journal of infectious diseasesSeptember 1, 2005Edwards RJ, Taylor GW, Ferguson M, Murray S, Rendell N, Wrigley A, Bai Z, Boyle J, Finney SJ, Jones A, et al.

(17) Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancerThe American journal of pathologyJune 1, 2005Huang J, Yao JL, Zhang L, Bourne PA, Quinn AM, di Sant'Agnese PA, Reeder JE.

(18) Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancerCancer researchMay 1, 2005Kim SJ, Uehara H, Yazici S, He J, Langley RR, Mathew P, Fan D, Fidler IJ.